Position history for ABN AMRO Bank N.V.'s holdings in VERTEX PHARMACEUTICALS INC
ABN AMRO Bank N.V. holds 118,349 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $53.3M as of 2026-Q1. The position was decreased (-23.8% shares). VRTX represents 0.6% of ABN AMRO Bank N.V.'s portfolio.
Current Value
$53.3M
Current Shares
118,349
Total Value Change
-$412,565
Total Shares Change
+4,830
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 118,349 |
-23.8% |
| $53.3M |
| 0.6% |
| $474.27 |
0 |
| 2025-Q4 | Increased | 155,221 | +9.4% | $70.1M | 0.7% | $453.74 | 46 |
| 2025-Q3 | Increased | 141,871 | +6.6% | $55.4M | 0.5% | $395.31 | 44 |
| 2025-Q2 | Increased | 133,072 | +4.5% | $59.6M | 0.8% | $441.30 | 43 |
| 2025-Q1 | Increased | 127,393 | +2.7% | $61.7M | 0.9% | $492.69 | 43 |
| 2024-Q4 | Increased | 124,052 | +6.3% | $49.5M | 0.7% | $399.35 | 44 |
| 2024-Q3 | Increased | 116,669 | +2.8% | $53.8M | 0.7% | $462.88 | 43 |
| 2024-Q2 | Increased | 113,519 | +2.0% | $53.7M | 0.8% | $468.72 | 42 |